Jan A. M. van Laar
Jan A. M. van Laar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ann Clementina Theodora Maria Vossen
Leiden University Medical Center, LUCID Medical Microbiology & Infection Control
1 shared publication Bart van Den Berg
1 shared publicationBjörn Hjálmarsson
1 shared publicationCorinne M. P. Buysse
1 shared publicationJaap Deinum
1 shared publicationKirsten van Lom
1 shared publication
Latest Publications
- 8 April 2002
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (7) , 837-839
Epstein-Barr Viral Load Assessment in Immunocompetent Patients With Fulminant Infectious Mononucleosis
We describe 2 immunocompetent adolescents with fulminant infectious mononucleosis and virus-associated hemophagocytosis. A new quantitative polymerase chain reaction revealed high serum Epstein-Barr virus DNA levels in these patients. One patient died with an increasing viral load not responding to corticosteroids followed by antiviral and intensified immunomodulatory treatment. The other patient received corticosteroids and acyclovir at diagnosis; her rapid recovery was heralded by a steep decline of viral load. We propose monitoring the clinical course of fulminant infectious mononucleosis in immunocompetent patients by Epstein-Barr virus DNA quantification and prompt corticosteroid and antiviral therapy when viral load is high.
- 8 April 2002
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (7) , 837-839
Epstein-Barr Viral Load Assessment in Immunocompetent Patients With Fulminant Infectious Mononucleosis
We describe 2 immunocompetent adolescents with fulminant infectious mononucleosis and virus-associated hemophagocytosis. A new quantitative polymerase chain reaction revealed high serum Epstein-Barr virus DNA levels in these patients. One patient died with an increasing viral load not responding to corticosteroids followed by antiviral and intensified immunomodulatory treatment. The other patient received corticosteroids and acyclovir at diagnosis; her rapid recovery was heralded by a steep decline of viral load. We propose monitoring the clinical course of fulminant infectious mononucleosis in immunocompetent patients by Epstein-Barr virus DNA quantification and prompt corticosteroid and antiviral therapy when viral load is high.